|
|
|
|
Department of Xenobiotic Metabolism and Disposition, Minase Research Institute, Ono Pharmaceutical Co., Ltd., Osaka, Japan (K.N.); and Division of Cancer Biology and Genetics, Queen's University Cancer Research Institute, Queen's University, Kingston, Ontario, Canada (C.E.G., D.Z., S.P.C.C., R.G.D.)
Multidrug resistance protein 1 (MRP1) transports a wide range of structurally diverse conjugated and nonconjugated organic anions and some peptides, including oxidized and reduced glutathione (GSH). The protein confers resistance to certain heavy metal oxyanions and a variety of natural product-type chemotherapeutic agents. Elevated levels of MRP1 have been detected in many human tumors, and the protein is a candidate therapeutic target for drug resistance reversing agents. Previously, we have shown that human MRP1 (hMRP1) and murine MRP1 (mMRP1) differ in their substrate specificity despite a high degree of structural conservation. Since rat models are widely used in the drug discovery and development stage, we have cloned and functionally characterized rat MRP1 (rMRP1). Like mMRP1 and in contrast to hMRP1, rMRP1 confers no, or very low, resistance to anthracyclines and transports the two estrogen conjugates, 17ß-estradiol-17-(ß-D-glucuronide) (E217ßG) and estrone 3-sulfate, relatively poorly. Mutational studies combined with vesicle transport assays identified several amino acids conserved between rat and mouse, but not hMRP1, that make major contributions to these differences in substrate specificity. Despite the fact that the rodent proteins transport E217ßG poorly and the GSH-stimulated transport of estrone 3-sulfate is low compared with hMRP1, site-directed mutagenesis studies indicate that different nonconserved amino acids are involved in the low efficiency with which each of the two estrogen conjugates is transported. Our studies also suggest that although rMRP1 and mMRP1 are 95% identical in primary structure, their substrate specificities may be influenced by amino acids that are not conserved between the two rodent proteins.
This article has been cited by other articles:
![]() |
H. Sun, L. Liu, and K. S. Pang Increased Estrogen Sulfation of Estradiol 17beta-D-Glucuronide in Metastatic Tumor Rat Livers J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 818 - 831. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Hanggi, A. F. Grundschober, S. Leuthold, P. J. Meier, and M. V. St-Pierre Functional Analysis of the Extracellular Cysteine Residues in the Human Organic Anion Transporting Polypeptide, OATP2B1 Mol. Pharmacol., September 1, 2006; 70(3): 806 - 817. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Deeley, C. Westlake, and S. P. C. Cole Transmembrane Transport of Endo- and Xenobiotics by Mammalian ATP-Binding Cassette Multidrug Resistance Proteins. Physiol Rev, July 1, 2006; 86(3): 849 - 899. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dallas, D. S. Miller, and R. Bendayan Multidrug resistance-associated proteins: expression and function in the central nervous system. Pharmacol. Rev., June 1, 2006; 58(2): 140 - 161. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tochigi, N. Yamashiki, S. Ohgiya, S. Ganaha, and H. Yokota ISOFORM-SPECIFIC EXPRESSION AND INDUCTION OF UDP-GLUCURONOSYLTRANSFERASE IN IMMUNOACTIVATED PERITONEAL MACROPHAGES OF THE RAT Drug Metab. Dispos., September 1, 2005; 33(9): 1391 - 1398. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Yu, K. von Bergmann, D. Lutjohann, H. H. Hobbs, and J. C. Cohen Selective sterol accumulation in ABCG5/ABCG8-deficient mice J. Lipid Res., February 1, 2004; 45(2): 301 - 307. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-W. Zhang, H.-M. Gu, D. Situ, A. Haimeur, S. P. C. Cole, and R. G. Deeley Functional Importance of Polar and Charged Amino Acid Residues in Transmembrane Helix 14 of Multidrug Resistance Protein 1 (MRP1/ABCC1): IDENTIFICATION OF AN ASPARTATE RESIDUE CRITICAL FOR CONVERSION FROM A HIGH TO LOW AFFINITY SUBSTRATE BINDING STATE J. Biol. Chem., November 14, 2003; 278(46): 46052 - 46063. [Abstract] [Full Text] [PDF] |
||||